Evidence map›Paper›PMID 32406606›Full record

ArticleActa ophthalmologica2020

Positive detection of SARS-CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct.

Yaguang Hu, Tianyan Chen, Miaomiao Liu, Li Zhang, Fang Wang, Shuo Zhao, Hui Liu, Han Xia, Yawen Wang, Li Li

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Acta ophthalmologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Ocular symptoms in COVID-19 infection: a survey study.Journal of ophthalmic inflammation and infection · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Evidence of SARS-CoV-2 Transmission Through the Ocular Route.Clinical ophthalmology (Auckland, N.Z.) · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Overlapping host pathways between SARS-CoV-2 and its potential copathogens: An in silico analysis.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. The Role of the Ocular Tissue in SARS-CoV-2 Transmission.Clinical ophthalmology (Auckland, N.Z.) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yaguang HuDepartment of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Tianyan ChenDepartment of Infectious Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Miaomiao LiuDepartment of Cardiac Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Li ZhangDepartment of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Fang WangDepartment of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Shuo ZhaoDepartment of Surgery Intensive Care Unit, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Hui LiuBiobank, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Han XiaFaculty of Electronic and Information Engineering, School of Automation Science and Engineering, Xi'an Jiaotong University, Xi'an, China.
Yawen WangDepartment of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Li LiDepartment of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.ORCID https://orcid.org/0000-0001-6682-6401
First Affiliated Hospital of Xi'an Jiaotong University · CNXi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe current outbreak of COVID-19 has spread rapidly all over the world. Respiratory droplets and contaction with infected patients are the two major transmission routes. However, the value of tear virus nucleic acid is still not clear. We dynamic detected the SARS-CoV-2 in eye sample of one COVID-19 patient with obstruction of common lacrimal ducts.

methodsBesides the routine examination, nasopharyngeal and eye swab were continuously measured by polymerase chain reaction assay and next-generation sequencing (NGS). Gene detection was performed for drug use guidance, and flow cytometry was performed to analyse the lymphocyte subsets.

resultsNasopharyngeal swabs were positive for 22 days, but eye swabs were still continuously positive for 2 weeks after nasopharyngeal swabs turned negative. The low level of lymphocyte and the high level IL-6 lasted for almost 4 weeks, then became near normal. Next-generation sequencing (NGS) confirmed the existing of SARS-CoV-2, HSV1 and HHV6B virus nucleic acid. The gene detection for drug use guidance showed the genetic locus ABCB1 (3435T>C) rs1045642 belonged to type CC and it mean the efficiency of lopinavir-ritonavir would be significantly decreased. The flow cytometry of lymphocyte subsets showed PD-1

conclusionsAs obstruction of common lacrimal duct, positively detection in one eye for 2 weeks more after nasopharyngeal swab became negative. More eye swabs should be collected from COVID-19 patients, especially from those immunocompromised, those with eye symptoms and those had a history of ocular diseases.

Indexed as

AgedAnti-Bacterial AgentsConjunctivaConjunctivitis, ViralCOVID-19COVID-19 Drug TreatmentDrug Therapy, CombinationEye Infections, ViralFlow CytometryHerpes SimplexHerpesvirus 1, HumanHerpesvirus 6, HumanHigh-Throughput Nucleotide SequencingHIV Protease InhibitorsHumansLacrimal Duct ObstructionAnti-Bacterial AgentsHIV Protease InhibitorsLopinavirMoxifloxacinNucleic AcidsRitonavirRNA, Viral

Identifiers

PMID32406606
PMCPMC7272962
OpenAlexW3024696527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.